DIA
Drug Information Association Logo
« Back to Listing

The Present and Future of Pharmaceutical Development Outsourcing: Where Are We Today and Where Are We Going?

Track:
Innovative Partnering Models and Outsourcing Strategies

Day & Time:
June 18, 10:30AM - 12:00PM (Pacific Standard Time)

Session Number:
331

Room Number:
4

Level:
Intermediate

Type:
Forum

Title:
The Present and Future of Pharmaceutical Development Outsourcing: Where Are We Today and Where Are We Going?

Chair(s):
Jon Meyer, MBA, MSc
Life Science Strategy Group, LLC, United States

Description:
Over the past decade, the pharmaceutical industry has increasingly turned to the use of outsourced service providers (CROs) for drug development as a strategy to cut internal costs, accelerate project timelines, and increase overall R&D efficiencies. During these last 10+ years, pharmaceutical sponsors have employed various strategies in working with CROs/outsourced partners, including the use of CROs in functional roles, use of a limited number of preferred partners, and even forming strategic partnerships over longer periods of time. This forum will present novel, proprietary data collected from a quantitative global sample of outsourcing professionals at biopharmaceutical companies to understand the frequency of use of various outsourcing models/strategies, sponsor satisfaction with the approaches and also explore how outsourcing methods/strategies are expected to evolve over the next five years. A diverse panel will provide commentary on the results of the research as the data are presented.

Learning Objective(s):
Describe the present and future use of outsourced development services including sponsor utilization of, satisfaction with, and rationale for use of models, including strategic partnerships, preferred partners, functional outsourcing, and other commonly used models.

Presentation(s) & Speaker(s):
The CRO-Sponsor Relationship – Then and Now: A Look at Past Outsourcing Models and Their Impact on Future Relationships
Andrew Townshend
Vice President, Alliance Development
INC Research, United States